BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8019663)

  • 1. New insights into the neurofibromatoses.
    Gutmann DH
    Curr Opin Neurol; 1994 Apr; 7(2):166-71. PubMed ID: 8019663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis and associated tumour suppressor genes.
    Zwarthoff EC
    Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic and molecular pathogenesis of NF1 and NF2.
    Yohay KH
    Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular-genetic aspects of neurofibromatosis].
    Hulsebos TJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):620-3. PubMed ID: 9190537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenesis in neurofibromatosis: new insights and potential therapies.
    Reed N; Gutmann DH
    Trends Mol Med; 2001 Apr; 7(4):157-62. PubMed ID: 11286939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of neurofibromatosis 1 and 2.
    Gutmann DH; Giovannini M
    Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurofibromatoses: when less is more.
    Gutmann DH
    Hum Mol Genet; 2001 Apr; 10(7):747-55. PubMed ID: 11257108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward the isolation and characterization of the genes causing neurofibromatosis.
    Menon AG; Gusella JF; Seizinger BR
    Brain Pathol; 1990 Sep; 1(1):33-40. PubMed ID: 1669691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of the neurofibromatosis type 1 gene and neurofibromin's role in cells].
    Sakai A
    Nihon Rinsho; 2000 Jul; 58(7):1426-9. PubMed ID: 10921317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1: piecing the puzzle together.
    Feldkamp MM; Gutmann DH; Guha A
    Can J Neurol Sci; 1998 Aug; 25(3):181-91. PubMed ID: 9706718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type 1.
    Colman SD; Wallace MR
    Eur J Cancer; 1994; 30A(13):1974-81. PubMed ID: 7734210
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosological considerations of the neurofibromatoses.
    Viskochil D; Carey JC
    J Dermatol; 1992 Nov; 19(11):873-80. PubMed ID: 1293176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing biologically targeted clinical trials for neurofibromatosis.
    Gutmann DH; Blakeley JO; Korf BR; Packer RJ
    Expert Opin Investig Drugs; 2013 Apr; 22(4):443-62. PubMed ID: 23425047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characterization of neurofibromatosis in southern Brazil.
    Rosset C; Vairo F; Cristina Bandeira I; Fonini M; Netto CBO; Ashton-Prolla P
    Expert Rev Mol Diagn; 2018 Jun; 18(6):577-586. PubMed ID: 29685074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
    Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H
    Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.
    Johnson MR; DeClue JE; Felzmann S; Vass WC; Xu G; White R; Lowy DR
    Mol Cell Biol; 1994 Jan; 14(1):641-5. PubMed ID: 8264632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis. Nosological considerations.
    Badiu C; Stefanache F
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):39-44. PubMed ID: 12089989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.